IPO News & Commentary
Get the latest insights on new stocks
- Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO 10/20/26
- Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO 10/20/26
- UK-based nursery operator iStep Learning files for a $18 million US IPO 10/19/26
- Chinese equipment maker Kepuni Holdings withdraws $15 million US IPO 10/19/26
- SPACCircle Acquisition lowers deal size by 33% ahead of $100 million IPO 10/19/26
- US IPO Weekly Winners & Losers 10/18/26
- International IPO Weekly Winners & Losers 10/18/26
See more
IPO News By Industry
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Hong Kong-based marketing firm AM PM Group doubles shares offered ahead of $34 million US IPO 08/27/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
NYSE IPO News
- Africa-linked IPOs pick up steam in 2026 10/20/26
- Pan-Asian travel booking platform Klook Technology withdraws estimated $400 million US IPO 10/16/26
- IPO Weekly Weigh-in: Why investors said no to this $3.5B AI IPO 10/14/26
- Emerging markets fintech OPay files for an estimated $500 million US IPO 10/09/26
- Cavity treatment provider vVardis files for an estimated $200 million US IPO 10/09/26
Nasdaq IPO News
- Inflammatory diseases biotech Rezera files for an estimated $100 million IPO 10/21/26
- China-based AI vision solutions provider Sensing4D AI files for a $35 million US IPO 10/21/26
- Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO 10/20/26
- Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO 10/20/26
- Chinese equipment maker Kepuni Holdings withdraws $15 million US IPO 10/19/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
Inflammatory diseases biotech Rezera files for an estimated $100 million IPO
Rezera, a Phase 3-ready biotech developing oral NLRP3 inhibitors for inflammatory diseases, filed on Wednesday with the SEC for an initial public offering. The company's filing included a placeholder deal size of $100 million. Rezera is developing oral...read more
China-based AI vision solutions provider Sensing4D AI files for a $35 million US IPO
Sensing4D AI, which provides AI-powered 3D vision, reconstruction, and digital twin solutions, filed on Wednesday with the SEC to raise up to $35 million in an initial public offering. Sensing4D AI provides AI-powered 3D vision solutions to enterprise clients ...read more
Africa-linked IPOs pick up steam in 2026
Africa-linked IPOs are having a strong year. Seven companies with significant African operations have raised at least $100 million via IPOs so far this year, totaling $2.6 billion in proceeds, more than each of the past five years. The pipeline is building, led ...read more